NYMOX PHARMACEUTICAL CORP·4

Jan 3, 1:05 PM ET

Danielsen Erik 4

4 · NYMOX PHARMACEUTICAL CORP · Filed Jan 3, 2019

Insider Transaction Report

Form 4
Period: 2018-12-19
Danielsen Erik
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-12-19$1.54/sh+5,000$7,71114,900 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT